VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases

Research on vaccines against trypanosomatids, a family of protozoa that cause neglected tropical diseases, such as Chagas disease, leishmaniasis, and sleeping sickness, is a current need. Today, according to modern vaccinology, virus-like particle (VLP) technology is involved in many vaccines, inclu...

Full description

Saved in:

Bibliographic Details
Published in:	Vaccines (Basel) Vol. 9; no. 3; p. 220
Main Authors:	Queiroz, Aline Maria Vasconcelos, Oliveira, Johny Wysllas de Freitas, Moreno, Cláudia Jassica, Guérin, Diego M A, Silva, Marcelo Sousa
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 05-03-2021 MDPI
Subjects:	Adjuvants African trypanosomiasis Antigens Chagas disease Context COVID-19 Cytokines Development strategies Gene expression Human papillomavirus Immune system Immunostimulation Infections Infectious diseases Leishmaniasis Parasites Parasitic diseases Protozoa Review Tropical diseases trypanosomatids Tumor necrosis factor-TNF vaccine Vaccines Vector-borne diseases Viral infections Virulence Virus-like particles Viruses trypanosomatids Chagas disease virus-like particles vaccine leishmaniasis African trypanosomiasis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!